SCHEMBL16092382

SCHEMBL16092382

CCc1c(-c2cn[nH]c2)[nH]c2c(C#N)cnn2c1=O

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KDM5A P29375 13/20 0.48
▸ KDM4E B2RXH2 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ KDM4C Q9H3R0 1/20 0.38
▸ PLAT P00750 2/20 0.35
▸ HPGD P15428 1/20 0.34
▸ KDM4D Q6B0I6 1/20 0.34
▸ ADORA2B P29275 2/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ RECQL P46063 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16092386 0.85 KDM5A (0.49) KDM5AKDM4EALDH1A1HSD17B10LMNA
SCHEMBL16047275 0.84 KDM5A (0.47) KDM5AKDM4EALDH1A1HSD17B10KDM4C
SCHEMBL16092553 0.82 KDM5A (0.46) KDM5AKDM4EALDH1A1HSD17B10KDM4C
SCHEMBL16050454 0.82 KDM5A (0.53) KDM5AKDM4C
SCHEMBL18159119 0.80 KDM5A (0.53) KDM5AKDM4EALDH1A1HSD17B10LMNA
SCHEMBL16049175 0.80 KDM5A (0.44) KDM5AKDM4EALDH1A1HSD17B10LMNA
SCHEMBL20426058 0.80 KDM5A (0.42) KDM5AKDM4D
SCHEMBL20427588 0.79 KDM5A (0.46) KDM5AKDM4EALDH1A1HSD17B10LMNA
SCHEMBL16092294 0.79 KDM5A (0.43) KDM5AKDM4EALDH1A1HSD17B10PLAT
SCHEMBL16050634 0.78 KDM5A (0.42) KDM5AKDM4EALDH1A1HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed
WO-2014139326-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2014-09-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10035801-B2 Pyrazolo compounds and uses thereof KDM5A, KDM5C, KDM5B KDM5A 1/4885KDM4E 12/4885ALDH1A1 1424/4885
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF KDM5A, KDM5C, KDM5B KDM5A 1/4885KDM4E 12/4885ALDH1A1 1424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback